CTRI/2020/06/026021已完成3 期
Performance Evaluation of VIDAS TB-IGRA assay-High Risk for latent Tuberculosis LTBI study. - NA
bioMerieux0 个研究点目标入组 37 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 37
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. A person who meets at least one of the criteria below, classifying him/her as being at increased risk for M. tuberculosis infection (and therefore LTBI) and/or for progression to active TB
排除标准
- •1. A person who has or has had active TB.
- •2. A person who has received treatment for active TB or LTBI
- •3. A person who has received an anti-TNF treatment within the previous 3 months
- •4. A person who has had a TST in the previous 12 weeks
- •5. Pregnant women (self-reported)
- •6. A person who has been diagnosed with a NTM infection
研究者
相似试验
已完成
不适用
Performance Evaluation of the VIDAS TB-IGRA Assay.Active TuberculosisLatent Tuberculosis InfectionNon-Tuberculous Mycobacterial (NTM) PneumoniaNCT04048018BioMérieux2,401
已完成
3 期
Evaluation of the performance of a new test for the diagnosis of active tuberculosis.CTRI/2020/06/026022BIOMERIEUX SA40
尚未招募
不适用
Analysis of IGRA negative tuberculosis patientstuberculosisJPRN-UMIN000018724Tohoku Pharmaceutical Univeristy Hospital10
已完成
不适用
Evaluation of the Innovance Immunoturbidimetric D-Dimer Assay for the Diagnosis of Disseminated Intravascular Coagulopathy (DIC) in different clinical settingsDisseminated Intravascular Coagulopathy (DIC)Blood - Clotting disordersACTRN12611001259932Pathology Dept. Launceston General Hospital, Launceston, Tasmania, Australia90
已完成
不适用
New Generation IGRA in Immunocompromised IndividualsMonitoring, ImmunologicActive TuberculosisTuberculosis in Solid Organ Transplant RecipientsTuberculosis in Marrow Transplant RecipientsTuberculosis in Rheumatoid ArthritisTuberculosis in Chronic Renal FailureTuberculosis in HIV-infected IndividualsNCT02639936Tuberculosis Network European Trialsgroup2,663